Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with multiple sclerosis, with a disability level that falls in a moderate range (EDSS score between 4 and 6.5)
- You have higher-than-normal blood pressure, meaning your systolic (top number) is above 120 mmHg or your diastolic (bottom number) is above 80 mmHg
- You currently do less than 60 minutes of physical activity per week
- Your body mass index (a measure of body weight relative to height) is below 40
- You are able to walk and are not fully dependent on a wheelchair
- You have had a multiple sclerosis relapse (a flare-up of symptoms) within the past 30 days
- Your current medications have been stable and unchanged (confirm with trial site)
Who may not be able to join:
- You have additional heart or blood vessel conditions beyond high blood pressure
- You have Type 1 diabetes
- Your doctor has advised against you taking part in the study
- There is not enough space in your home to fit an exercise bike (cycle ergometer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bo Fernhall, PhD, University of Massachusetts, Boston
Phone: 2178404493
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Information processing speed; Timed 25-Foot Walk
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.